Technology Transfer

作为一个独立的技术转让办公室，技术转让和创新访问办公室（OTTIA）提供一系列完整的服务，支持国家牙科和颅面研究所（NIDCR）的技术开发活动。 为了确保这些活动符合联邦法规、条例和国立卫生研究院的政策，OTTIA的大部分职责包括NIDCR与外部各方（包括大学、制药和生物技术公司）之间交易协议的日常谈判。 同时，OTTIA通过促进科学交流，促进NIDCR研究，并获得物质和财政资源，扩大了NIDCR校内研究的影响。 协定有助于： * 根据《材料转让协定》交换研究材料; * 根据合作研究及发展协议进行的合作研究; * 进行临床研究，以确定根据临床合作研究及发展协定所采用的新药物及器材的安全性及成效; * 根据保密披露及资料共用协议交换保密资料或资料;以及 * 为商业评估、产品开发、内部私营部门研究用途的技术颁发许可证，并支持外部非营利技术转让工作。 OTTIA审查员工发明报告，评估专利性，评估商业潜力，并就国内外专利申请的提交做出决定。 我们监督NIDCR拥有的发明的专利申请和相关法律的合同的履行。 我们开展营销活动，以许可这些发明，并制定和/或评估发展战略，使技术取得成果。 OTTIA将协议和发明工作整合起来，制定合作伙伴关系战略，从而补充和扩展NIDCR的能力，以更好地实现我们的使命目标。 我们的工作人员参加会议，讨论和会议，适当的，保持了解和监测科学家的需求，并从NIH和更广泛的技术转让社区作出贡献和学习。

As a stand alone technology transfer office, the Office of Technology Transfer and Innovation Access (OTTIA) provides a complete array of services, supporting the National Institute of Dental and Craniofacial Research (NIDCR)'s technology development activities. To ensure that these activities comport with Federal statutes, regulations and the policies of the National Institutes of Health, a large part of OTTIA's responsibilities includes the day-to-day negotiations of transactional agreements between the NIDCR and outside parties, including universities, pharmaceutical and biotechnology companies. Concurrently, OTTIA broadens the impact of NIDCR intramural research by fostering scientific exchange, promoting NIDCR research, and obtaining material and financial resources. Agreements facilitate: *exchanges of research materials under the Material Transfer Agreements (MTAs); *collaborative research conducted under cooperative research and development agreements (CRADAs); *clinical studies to determine the safety and efficacy of new agents and devices under clinical CRADAs; *exchanges of confidential information or data under confidential disclosure and data sharing agreements (CDAs, DSAs); and *licensing of technologies for commercial evaluation, product development, internal private-sector research use, and support of external non-profit technology transfer efforts. OTTIA reviews employee invention reports, assesses patentability, evaluates commercial potential, and makes decisions concerning filing of domestic and foreign patent applications. We monitor the patent prosecution, and fulfilment of associated legal contracts, for NIDCR-owned inventions. We conduct marketing activities to license those inventions and develop and/or assess development strategies to bring technologies to fruition. OTTIA integrates the agreement and invention work to develop strategies for partnerships, thus complementing and extending NIDCRs capabilities to better meet our mission goals. Our staff participates in meetings, discussions and conferences, as appropriate, to stay apprised of and monitor scientists' needs, and to both contribute and learn from the NIH and broader Technology Transfer communities.